Sami Belhadj

10PUBLICATIONS
66CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsLiquid biopsiesPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 19, 2026
Sequencing approaches in hereditary cancer testing: strengths, limitations and future directions.

Sami Belhadj, Christopher J Hatch, Holly LaDuca

|Nov 08, 2022
NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.

Sami Belhadj, Aliya Khurram, Chaitanya Bandlamudi

|Aug 09, 2022
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities.

Kenneth Offit, Catherine M Sharkey, Dina Green

|Apr 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.

Semanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann

|Nov 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations.

Ying L Liu, Karen A Cadoo, Semanti Mukherjee

Pageof 2